Santa Cruz Biotechnology offers a broad range of HIV gp24 monoclonal antibodies for research in understanding HIV infection and pathogenesis. HIV gp24 monoclonal antibodies are suitable for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). HIV gp24 is a critical component of the HIV virus, serving as a major structural protein that plays a key role in viral assembly and maturation. Its presence is essential for the virus's ability to infect host cells, making it a significant target for diagnostic and therapeutic strategies. Understanding the function of HIV gp24 is crucial for developing effective treatments and vaccines against HIV/AIDS. Research focusing on HIV gp24 continues to reveal new insights into viral mechanisms and potential therapeutic approaches. Investigating HIV gp24 interactions with host cells provides valuable information about viral entry and replication processes. Advanced research techniques using HIV gp24 monoclonal antibodies help identify potential drug targets and vaccine candidates. Santa Cruz Biotechnology monoclonal antibodies for HIV gp24 support researchers worldwide in their mission to combat HIV/AIDS through innovative scientific discoveries.